Evidence map›Paper›PMID 27188377›Full record

ArticleWomen's health (London, England)2016

Outcomes of implementing the women's health assessment tool and clinical decision support toolkit.

Terry Silvestrin, Anna Steenrod, Karin Coyne, David Gross, Canan Esinduy, Angela Kodsi, Gayle Slifka, Lucy Abraham, Anna Araiza, Andrew Bushmakin and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Women's health (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Terry SilvestrinMultiCare Tacoma Women's Specialists, Tacoma, WA, USA.
Anna SteenrodEvidera, Bethesda, MD, USA.
Karin CoyneEvidera, Bethesda, MD, USA.
David GrossPfizer, Inc., NY, USA.
Canan EsinduyPfizer, Inc., NY, USA.
Angela KodsiPfizer, Inc., NY, USA.
Gayle SlifkaPfizer, Inc., NY, USA.
Lucy AbrahamPfizer, Inc., NY, USA.
Anna AraizaPfizer, Inc., NY, USA.
Andrew BushmakinPfizer, Inc., NY, USA.
Xuemei LuoPfizer, Inc., NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate outcomes after implementing the women's health assessment tool (WHAT) and clinical decision support toolkit during annual well-women visits.

methodsAn observational project involved women aged 45-64 years attending one of three medical sites in Washington (WA, USA). Responses to the WHAT questionnaire and patients' health resource utilization prepost toolkit implementation were analyzed.

resultsA total of 110 women completed the WHAT questionnaire. Majority of women were postmenopausal (77.3%) and experienced depressive mood (63.6%), hot flashes (61.8%) or anxiety (60.9%) in the last 3 months. There was a 72.2% increase in the number of diagnoses made during the annual visit versus the previous 12 months.

conclusionThe WHAT/clinical decision support toolkit helped identify conditions relevant to mid-life women.

Indexed as

PremenopauseWomen's HealthAnxietyDepressionFemaleHot FlashesHumansMiddle AgedOutcome Assessment, Health CareQuality of LifeSurveys and Questionnairesclinical decision support systemhealth outcomemenopause

Identifiers

PMID27188377
PMCPMC5384517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.